Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post appeared first on investingnews.com Prev Post 5 Biggest Blockchain ETFs in 2025 June 4, 2025 Next Post Adam Rozencwajg: Gold Stock Gains, Silver and Uranium Prices — Plus PGMs Bull Case June 4, 2025 Related Posts Rio Silver Now Trading on U.S. OTCID Market, Expanding Access for United States and Global Investors February 10, 2026 Oreterra Announces $6,000,000 Private Placement to Support First-Ever Drilling of the Trek South Porphyry Copper-Gold Prospect, Golden Triangle, BC February 10, 2026 Cardiol Therapeutics’ ARCHER Phase II Study Results Published in ESC Heart Failure February 10, 2026
Rio Silver Now Trading on U.S. OTCID Market, Expanding Access for United States and Global Investors February 10, 2026
Oreterra Announces $6,000,000 Private Placement to Support First-Ever Drilling of the Trek South Porphyry Copper-Gold Prospect, Golden Triangle, BC February 10, 2026